And shake off your neoliberal chains.

Kurt Schrader helped bury prescription drug reform. And now he seems to have a tough primary next Tuesday.

A conversation with Alexander Zaitchik, author of “Owning the Sun: A People’s History of Monopoly Medicine From Aspirin to Covid-19 Vaccines”

The massive government interventions that buffered Covid-19’s ravages are fading away, returning us to an unacceptable status quo.

A $26 billion deal is now in local governments’ hands. It could go to harm reduction or toward police and politicians’ pet concerns.

Lawmakers are touting a proposed cap on prices, but the benefit won’t swing to the patients with the most desperate needs.

The celebrity mogul wants to kill our dysfunctional health care system with kindness, but it will take a lot more than that.

The congressman leading the fight to kill his party’s prescription drug proposal has been taking checks from pharmaceutical interests this whole time.

The Arizona senator wants to cut funding for climate-change policies and opposes a plan to rein in prescription drug prices. She doesn’t deserve the Democratic Party.

The industry’s titanic profits power a perpetual stranglehold over our government with only one goal in mind: raking you clean of every last dime.

Twenty years ago, you could get a vaccine for Lyme disease. Now you can’t. What happened?

The big-box retailer has found a way to monetize the nation’s desperation.

The FDA should be our toughest regulatory body, but the pharmaceutical lobby has torn it to shreds.

Not long ago, life-saving medical know-how was viewed as belonging to everyone. What happened?

Corporate America might protest, but the potential of a patent waiver on Covid-19 vaccines is worth celebrating—and fighting for.

Through his hallowed foundation, the world’s de facto public health czar has been a stalwart defender of monopoly medicine.

You might think you’re just getting the Covid vaccine, but the chains rolling them out are trying to hook a customer for life.

The race for a cure has put a spotlight on corporate control over medical research. Under a Democratic administration, it doesn’t have to be that way.

America is putting an awful lot of trust in a pharmaceutical industry that hasn’t earned it.

The mass expansion of public goods is long past due, so pay people to stay home, give them free health care, and stop charging tuition.